Literature DB >> 15542281

Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia.

Marc S Sabatine1, David A Morrow, James A de Lemos, Torbjorn Omland, Milind Y Desai, Milenko Tanasijevic, Christian Hall, Carolyn H McCabe, Eugene Braunwald.   

Abstract

OBJECTIVES: The aim of this study was to determine the effect of transient myocardial ischemia on circulating natriuretic peptide levels.
BACKGROUND: Natriuretic peptides are released by the heart in response to wall stress. We hypothesized that transient myocardial ischemia would cause acute changes in circulating natriuretic peptide levels.
METHODS: B-type natriuretic peptide (BNP), N-terminal fragment of BNP pro-hormone (NT-pro-BNP), and N-terminal fragment of atrial natriuretic peptide pro-hormone (NT-pro-ANP) levels were measured in 112 patients before, immediately after, and 4 h after exercise testing with nuclear perfusion imaging.
RESULTS: Baseline levels of BNP were associated with the subsequent severity of provoked ischemia, with median levels of 43, 62, and 101 pg/ml in patients with none, mild-to-moderate, and severe inducible ischemia, respectively (p = 0.03). Immediately after exercise, the median increase in BNP was 14.2 pg/ml in patients with mild-to-moderate ischemia (p = 0.0005) and 23.7 pg/ml in those with severe ischemia (p = 0.017). In contrast, BNP levels only rose by 2.3 pg/ml in those who did not develop ischemia (p = 0.31). A similar relationship was seen between baseline NT-pro-BNP levels and inducible ischemia, but the changes in response to ischemia were less pronounced. NT-pro-ANP levels rose with exercise in both ischemic and non-ischemic patients. When added to traditional clinical predictors of ischemia, a post-stress test BNP >or=80 pg/ml remained a strong and independent predictor of inducible myocardial ischemia (odds ratio 3.0, p = 0.025).
CONCLUSIONS: Transient myocardial ischemia was associated with an immediate rise in circulating BNP levels, and the magnitude of rise was proportional to the severity of ischemia. These findings demonstrate an important link between the severity of an acute ischemic insult and the circulating levels of BNP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542281     DOI: 10.1016/j.jacc.2004.07.057

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  68 in total

Review 1.  Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure.

Authors:  Chaitanya Madamanchi; Hassan Alhosaini; Arihiro Sumida; Marschall S Runge
Journal:  Int J Cardiol       Date:  2014-08-09       Impact factor: 4.164

2.  Institute for Quality in Laboratory Medicine series--controversies in laboratory medicine: insights into B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide measurements.

Authors:  Robert H Christenson; W H Wilson Tang
Journal:  MedGenMed       Date:  2006-05-31

Review 3.  Assessment of cardiac risk before non-cardiac general surgery.

Authors:  Olaf Schouten; Jeroen J Bax; Don Poldermans
Journal:  Heart       Date:  2006-12       Impact factor: 5.994

4.  Effects of lesion complexity on baseline and postprocedural B-type natriuretic peptide levels in patients undergoing percutaneous coronary interventions.

Authors:  Aylin Yildirir; Sadik Acikel; Cagatay Ertan; Alp Aydinalp; Bulent Ozin; Haldun Muderrisoglu
Journal:  Tex Heart Inst J       Date:  2007

5.  Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35.

Authors:  Marc S Sabatine; David A Morrow; James A de Lemos; Petr Jarolim; Eugene Braunwald
Journal:  Eur Heart J       Date:  2008-11-08       Impact factor: 29.983

6.  What Is the Meaning of Increased Myocardial Injury Enzymes during Hemodialysis? A Tissue Doppler Imaging Study.

Authors:  Gürsel Yildiz; Mansur Kayataş; Ferhan Candan; Mehmet Birhan Yilmaz; Ali Zorlu; Savaş Sarikaya
Journal:  Cardiorenal Med       Date:  2013-06-25       Impact factor: 2.041

Review 7.  Natriuretic peptide-guided treatment for the prevention of cardiovascular events in patients without heart failure.

Authors:  Claire Sweeney; Fiona Ryan; Mark Ledwidge; Cristin Ryan; Ken McDonald; Chris Watson; Rebabonye B Pharithi; Joe Gallagher
Journal:  Cochrane Database Syst Rev       Date:  2019-10-15

8.  B-type natriuretic peptide in reversible myocardial ischaemia.

Authors:  K Chatha; M Alsoud; M J Griffiths; A Elfatih; K Abozguia; R C Horton; S J Dunmore; R Gama
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

9.  The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology.

Authors:  Van Kimmenade
Journal:  Biomark Insights       Date:  2007-02-07

10.  B-type natriuretic peptide release and left ventricular filling pressure assessed by echocardiographic study after subarachnoid hemorrhage: a prospective study in non-cardiac patients.

Authors:  Eric Meaudre; Christophe Jego; Nadia Kenane; Ambroise Montcriol; Henry Boret; Philippe Goutorbe; Gilbert Habib; Bruno Palmier
Journal:  Crit Care       Date:  2009-05-20       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.